Related content

Genetic polymorphism of cytochrome P₄₅₀ 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

By Lee Ai-Young   Kim Min-Jung   Chey Won-Young   Choi Jun   Kim Byung-Gun  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Fatal intoxication cases: cytochrome P ₄₅₀ 2D6 and 2C19 genotype distributions

By Zackrisson A.   Holmgren P.   Gladh A.   Ahlner J.   Lindblom B.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 547-552

Springer Publishing Company

Access to resources Recommend Favorite

Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P ₄₅₀ 2D6 gene

By Hedenmalm Karin   Lindh Jonatan   Säwe Juliette   Rane Anders  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 369-372

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the novel anxiolytic drug deramciclane on cytochrome P ₄₅₀ 2D6 activity as measured by desipramine pharmacokinetics

By Laine Kari   Bruyn Steven   Björklund Harry   Rouru Juha   Hänninen Jutta   Scheinin Harry   Anttila Markku  

European Journal of Clinical Pharmacology, Vol. 59, Iss. 12, 2004-02 ,pp. : 893-898

Springer Publishing Company

Access to resources Recommend Favorite

Identification of cytochromes P₄₅₀ 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro

By Ufer Mike   Svensson Jan   Krausz Kristopher   Gelboin Harry   Rane Anders   Tybring Gunnel  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite